Reports for BAYER INC
Company Name
BAYER INC
Totals |
||
Shortage reports |
87 |
|
Actual shortage: | 4 (5%) | |
Anticipated shortage: | 2 (2%) | |
Avoided shortage: | 10 (11%) | |
Resolved: | 71 (82%) | |
Discontinuation Reports |
23 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 22 (96%) | |
Reversed: | 1 (4%) | |
Late reports |
6 (5%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ULTRAVIST 370 | 77% | SOLUTION | Resolved | 2024-01-12 | 2024-05-06 | 215787 |
XARELTO | 10MG | TABLET | Resolved | 2024-04-25 | 2024-05-21 | 226202 |
CLIMARA 25 | 25MCG | PATCH | Resolved | 2024-01-17 | 2024-06-03 | 216236 |
ULTRAVIST 300 | 62% | SOLUTION | Resolved | 2024-01-12 | 2024-06-03 | 215772 |
CLIMARA 50 | 50MCG | PATCH | Resolved | 2024-04-17 | 2024-06-04 | 225331 |
XARELTO | 10MG | TABLET | Anticipated shortage | 2024-06-07 | 2024-06-07 | 229971 |
CIPRO ORAL SUSPENSION | 500MG | SUSPENSION | Anticipated shortage | 2024-06-07 | 2024-06-07 | 229988 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
GLUCOBAY | 100MG | TABLET | Discontinued | 2023-07-11 | 2023-07-11 | 198128 |
GLUCOBAY | 50MG | TABLET | Discontinued | 2023-07-11 | 2023-07-11 | 198131 |
STAXYN | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-07-14 | 2023-07-14 | 198701 |